Nadia Waheed, Chief Medical Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 27,722 shares at $8.05 ($223K) on 2025-06-02, disclosed to the SEC on 2025-06-03.
Scheduled sale ($223k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.05 | 13,861 | $112K | 50.0% |
| 2 | $8.05 | 13,861 | $112K | 50.0% |
| Total | $8.05 avg | 27,722 | $223K | 100% |
| Filing → |
| OCUL | SELL | 2026-02-17 | $71K | — | Filing → |